Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Peter Marks

US panel recommends Covid vaccine for youngest children

Washington (AFP) - After months of waiting for anxious parents, a panel of experts convened by the US Food and Drug Administration recommended Moderna's Covid vaccine Wednesday for the nation's youngest children.

AFP

FDA advisers weigh COVID-19 shots for babies, young children

U.S. government advisers met Wednesday to decide whether to endorse COVID-19 shots for the youngest children, moving the nation closer to vaccinations for all ages

The Independent UK

FDA advisers back Novavax COVID-19 shots as new US option

A more traditional kind of COVID-19 vaccine has moved a step closer to the U.S. market

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA authorizes first COVID booster for children ages 5 to 11

The Food and Drug Administration expanded authorization of Pfizer-BioNTech's COVID vaccine to enable kids ages 5 to 11 who were vaccinated at least five months ago to get a third shot.

WEKU

The U.S. Is About to Make a Big Gamble on Our Next COVID Winter

Experts are expected to choose a vaccine recipe for the fall, when Omicron may or may not still be the globe’s dominant variant.

The Atlantic

Emergent's Covid vaccine problems more extensive than previously known

Lawmakers detail how 400 million Covid-19 doses were destroyed at the company’s Baltimore facility after it failed to heed internal warnings about quality standards.

Politico

US Drug Regulator Limits Use of J&J Covid Vaccine

The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition. The vaccine, which was authorized as a single shot,…

Asharq Al-Awsat

Read news from The Economist, FT, and more,
with one subscription

FDA limits use of Johnson & Johnson COVID vaccine over blood clot risks, agency says

The use of Johnson and Johnson’s COVID-19 vaccine, also known as Janssen, has been limited to “certain individuals” over rare blood clot risks, the U.S. Food and Drug Administration announced Thursday, May 5.

McClatchy Washington Bureau

US drug regulator limits use of J&J Covid vaccine

Washington (AFP) - The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson amp; Johnson Covid shot, which has been linked to a rare but serious clotting condition.

AFP

Moderna seeks FDA approval of Covid vaccine for children aged six months to five years old

The request arrives one month after the drug company said its two-dose jabs provided immune protection in youngest children

The Independent UK

Moderna seeks to be 1st with COVID shots for littlest kids

Moderna is asking U.S. regulators to open its COVID-19 vaccine to the nation's youngest children

The Independent UK

Moderna asks FDA to authorize Covid-19 vaccine for young kids

The request comes a month after the drug company signaled its two-dose regimen generated immune protection in the youngest children comparable to young adults.

Politico

Most Americans have COVID-19 antibodies as case numbers rise - Roll Call

The percentage of people with antibodies increased from 34 percent in December to roughly 58 percent in February, the CDC said.

Roll Call

Pryzm owner to open 10 new bars in the UK as nightlife recovers

Rekom’s 48 British outlets have seen attendance return to pre-pandemic levels

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Politico

3 takeaways ahead of potential fall Covid booster campaign

Panel members agreed that myriad unknowns persist about the coronavirus and how it might evolve.

The Independent UK

US experts discuss COVID boosters for the fall and beyond

Vaccine experts are meeting to discuss the U.S. strategy for future COVID-19 booster campaigns

Los Angeles Times

Now is the time to get a second COVID-19 booster shot, health official advises

LOS ANGELES — Now is the time for those at higher risk from COVID-19 to get a second booster dose, Los Angeles County’s public health director said, citing less-than-ideal overall vaccination rates along with concerns swirling around the rapid spread of the highly contagious BA.2 omicron subvariant.

The Guardian - US

‘This massive undertaking was invisible’: film glimpses behind the curtain as Covid vaccine was made

Acclaimed film-maker David France’s How to Survive a Pandemic on HBO documents ‘a scientific undertaking unlike any in our lifetime’

Get all your
news in one place.

100’s of premium titles.
One news app.

Axios

America's choose-your-own-adventure vaccine approach could create confusion

The gap between the under-vaccinated and the ultra-vaccinated will continue to grow.

Tribune News Service

FDA clears way for millions to get additional COVID-19 boosters

WASHINGTON — U.S. regulators cleared second booster doses of COVID-19 vaccine from Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE for adults 50 and older, making millions more people eligible for the shots as concern grows about a potential new wave of infections.

Politico

CDC recommends additional booster of Pfizer-BioNTech, Moderna Covid-19 vaccine for adults 50 and older

The recommendations also include another Pfizer-BioNTech booster for immunocompromised people 12 and older.

Politico

FDA delays meeting on kid vaccines as Pfizer promises more data

The companies have been testing a third shot after announcing in December that trial data showed two doses produced an insufficient immune response in toddlers.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

309 stories

Centers for Disease Control and Prevention

US Food and Drug Administration

67 stories

University of Washington

63 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.